EU Business News: GSK Consumer Gets New Name, Navamedic Strikes Ipsen Deal, Enzymatica Optimistic After Tough Year

 
• By Tom Gallen

Round-up of the latest European consumer health business news: GSK reveals name for standalone consumer health business will be Haleon; Norways' Navamedic strikes a distribution deal with Ipsen for select GI OTC products; and Sweden's Enzymatica hopeful that changed consumer behaviors will help its sales rebound in 2022.

Business model (everything possible/Shutterstock.com)
• Source: Shutterstock

GlaxoSmithKline’s Consumer Healthcare business will operate under the name Haleon when it demerges from the larger group later this year.

The name Haleon, GSK explained, was inspired by the merging of the words “Hale” – an old English word that means “in good health” – and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography